News
Women's health doctor Ravina Bhanot, from Zonas Fertility, told LADbible: "Hair loss while taking Mounjaro is a common side effect due to rapid weight loss. It is more likely linked to caloric ...
4h
Asianet Newsable on MSNHims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent ExpiresThe telehealth company stated that its entry to Canada will come as generic Semaglutide hits the market for the first time.
The Advertising Standards Authority said the rulings made it ‘crystal clear’ that prescription-only medicines could not be ...
Novo Nordisk's beaten-down valuation became too attractive to pass up, so I bought the stock earlier this year. Eli Lilly's ...
U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...
Learn how the benefits of GLP-1s may be outweighed by the risks.
Hims and Hers announced this morning that it will begin offering compounded semaglutide (generic Ozempic or Wegovy) for $199 ...
The drug coverage provision does not mention any specific drug by name, but it could include the GLP-1 agonists, such as ...
A County Durham woman who lost 16 stone without drugs says she believes that slimming clubs are still needed despite the ...
The recent approval of weight-loss drug Wegovy in New Zealand has been hyped as a breakthrough in the country’s fight against ...
ASA said the advert posted to her Instagram, which is still live, would 'likely' encourage people to 'request the ...
Hims & Hers announced plans to expand its weight loss program to Canada in 2026 in connection with the availability of generic semaglutide anywhere in the world.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results